Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v5-FR
Language French French
Date Updated 2025-04-03 2025-01-09
Drug Identification Number 02229048 02229048
Brand name ISOVUE 370 INJECTION ISOVUE 370 INJECTION
Common or Proper name IsoVue 370 IsoVue 370
Company Name BRACCO IMAGING CANADA BRACCO IMAGING CANADA
Ingredients IOPAMIDOL IOPAMIDOL
Strength(s) 76% 76%
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVASCULAR INTRAVASCULAR INTRAVASCULAR INTRAVASCULAR
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes box of 10 vials of 100ml box of 10 vials of 100ml
ATC code V08AB V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2024-11-27 2024-11-27
Actual start date 2024-11-25 2024-11-25
Estimated end date 2025-04-18 2025-01-29
Actual end date 2025-04-04
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Increase demand for this format due to supply chain issue for IsoVue 370 10X200ml and IsoVue 370 6 X 500ml impacted by the strike/lockout at port of Montreal
Health Canada comments